摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(6R)-2-{(E)-(pyrid-4-yl)methylene}-1-oxocyclohex-6-yl]azetidin-2-one | 208191-56-4

中文名称
——
中文别名
——
英文名称
(3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(6R)-2-{(E)-(pyrid-4-yl)methylene}-1-oxocyclohex-6-yl]azetidin-2-one
英文别名
(3S,4R)-3-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-4-[(1R,3E)-2-oxo-3-(pyridin-4-ylmethylidene)cyclohexyl]azetidin-2-one
(3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(6R)-2-{(E)-(pyrid-4-yl)methylene}-1-oxocyclohex-6-yl]azetidin-2-one化学式
CAS
208191-56-4
化学式
C23H34N2O3Si
mdl
——
分子量
414.62
InChiKey
YTZCQIZYNXHWLO-YMASDYJYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    559.7±50.0 °C(Predicted)
  • 密度:
    1.097±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.36
  • 重原子数:
    29.0
  • 可旋转键数:
    5.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    68.29
  • 氢给体数:
    1.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    (3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(6R)-2-{(E)-(pyrid-4-yl)methylene}-1-oxocyclohex-6-yl]azetidin-2-one碳酸氢钠 作用下, 以 异辛烷二氯甲烷环己烷甲苯 为溶剂, 反应 2.5h, 生成 9H-fluoren-9-ylmethyl (1S,6E,9aS,9bR)-1-(1-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}ethyl)-2-oxo-6-(4-pyridinylmethylidene)-1,2,6,7,8,9,9a,9b-octahydroazeto[2,1-a]isoindole-4-carboxylate
    参考文献:
    名称:
    The Synthesis of GV143253A: A Case Study for the Use of Analytical and Statistical Tools to Elucidate the Reaction Mechanism and to Optimize the Process
    摘要:
    GV143253A 1 is a broad-spectrum injectable beta-lactam belonging to the class of trinem antibiotics. This article describes the work which enabled a detailed process understanding via several analytical techniques and the subsequent optimization of a key intermediate. By means of a combined application of (31)P NMR spectroscopy and MS spectrometry, the main impurities have been identified and the reaction mechanisms clarified. Moreover, a design of experiments (DoE) approach was applied which substantially improved the overall yield.
    DOI:
    10.1021/op100097c
  • 作为产物:
    参考文献:
    名称:
    Preparation of the Key Intermediate in the Synthesis of GV143253A:  The Anti-MRSA/E Injectable Trinem
    摘要:
    GV143253A is a broad-spectrum injectable beta-lactam belonging to the class of trinem antibiotics. A key intermediate (3S,4R)-3-[(1R)-1-(tert-butyldimethyl- silyloxy)ethyl]-4-[-(6'R)-2'-[(E)(pyrid-4yl)methylene]-1'-oxocyclohex-6'-yl]azetidin-2-one (10) was identified and synthesized via different enolate coupling approaches, using enol ether, lithium, sodium, magnesium, tin, zinc, zirconium, and titanium enolates. Among these approaches, the synthesis of (3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[-(6'R)-2'-[(E)-(pyrid-4yl)-methylene]-1'-oxo- cyclohex-6'-yl]azetidin-2-one (10) via a titanium enolate offered advantages in terms of greater diastereoselectivity, higher yield, robustness, and isolation of intermediates and was superior to the method previously used for preparing large quantities of drug substance for early development studies.
    DOI:
    10.1021/op020024l
点击查看最新优质反应信息

文献信息

  • Preparation of the Key Intermediate in the Synthesis of GV143253A:  The Anti-MRSA/E Injectable Trinem
    作者:Paolo Maragni、Mario Mattioli、Roberta Pachera、Alcide Perboni、Bruno Tamburini
    DOI:10.1021/op020024l
    日期:2002.9.1
    GV143253A is a broad-spectrum injectable beta-lactam belonging to the class of trinem antibiotics. A key intermediate (3S,4R)-3-[(1R)-1-(tert-butyldimethyl- silyloxy)ethyl]-4-[-(6'R)-2'-[(E)(pyrid-4yl)methylene]-1'-oxocyclohex-6'-yl]azetidin-2-one (10) was identified and synthesized via different enolate coupling approaches, using enol ether, lithium, sodium, magnesium, tin, zinc, zirconium, and titanium enolates. Among these approaches, the synthesis of (3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[-(6'R)-2'-[(E)-(pyrid-4yl)-methylene]-1'-oxo- cyclohex-6'-yl]azetidin-2-one (10) via a titanium enolate offered advantages in terms of greater diastereoselectivity, higher yield, robustness, and isolation of intermediates and was superior to the method previously used for preparing large quantities of drug substance for early development studies.
  • The Synthesis of GV143253A: A Case Study for the Use of Analytical and Statistical Tools to Elucidate the Reaction Mechanism and to Optimize the Process
    作者:Giuseppe Guercio、Alcide Perboni、Francesco Tinazzi、Luca Rovatti、Stefano Provera
    DOI:10.1021/op100097c
    日期:2010.7.16
    GV143253A 1 is a broad-spectrum injectable beta-lactam belonging to the class of trinem antibiotics. This article describes the work which enabled a detailed process understanding via several analytical techniques and the subsequent optimization of a key intermediate. By means of a combined application of (31)P NMR spectroscopy and MS spectrometry, the main impurities have been identified and the reaction mechanisms clarified. Moreover, a design of experiments (DoE) approach was applied which substantially improved the overall yield.
查看更多

同类化合物

(6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 顺式-4-(2,2-二甲氧基乙基)-3-邻苯二甲酰-2-氮杂环丁酮 顺式-1-(对甲苯基)-3-苄氧基-4-(对茴香基)-氮杂环丁烷-2-酮 青霉酰聚赖氨酸 青霉素钾 青霉素钠 青霉素酶液体 青霉素杂质C 青霉素G衍生物 青霉素G甲酯 青霉素G甲酯 青霉素G-D7 青霉素 V 钠 阿那白滞素 阿莫西林钠 阿莫西林三水合物 阿莫西林 阿立必利D5 阿度西林 铜(2+)酞菁-29,30-二负离子-2-(二甲氨基)乙醇(1:1:1) 钾(2S,5R,6R)-6-[[2-[(E)-3-氯丁-2-烯基]巯基乙酰基]氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸酯 钠(6S,7R)-3-(羟基甲基)-7-甲氧基-8-氧代-7-[(2-噻吩基乙酰基)氨基]-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸酯 酞氨西林 萘夫西林杂质 苯磺酸,2-[(2-羟基-1-萘基)偶氮]-5-甲基-,盐(2:1)钡 苯氧乙基青霉素钾 苯唑西林钠 苯唑西林杂质1 舒巴坦杂质19 舒他西林 脱乙酰基戊二酰 7-氨基头孢烷酸 脱乙酰基头孢噻肟 肟莫南 羰苄西林苯酯钠 美罗培南钠盐 美罗培南 美洛培南 缩酮氨苄青霉素 紫杉醇侧链2 硫霉素 硫霉素 硫酸氢3-{[(6R,7R)-7-{[(2E)-2-(2-氨基-1,3-噻唑-4-基)-2-(甲氧基亚氨基)乙酰基]氨基}-2-羧基-8-羰基-5-硫杂-1-氮杂二环[4.2.0]辛-2-烯-3-基]甲基}-1,3-噻唑-3-正离子 硫酸头孢噻利 硫酸头孢喹诺 盐酸巴氨西林 盐酸头孢唑兰 盐酸头孢吡肟 盐酸头孢他美酯 盐酸头孢他美 癸二酸与六氢-2H-氮杂卓-2-酮,1,6-己烷二胺和己二酸的聚合物